Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alzheimer disease | D000544 | EFO_0000249 | F03 | 3 | 3 | 1 | — | — | 6 |
Dementia | D003704 | EFO_0003862 | F03 | 1 | 1 | 1 | — | — | 2 |
Asymptomatic diseases | D058070 | — | — | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 9 | — | — | — | — | 9 |
Drug common name | Atabecestat |
INN | atabecestat |
Description | Atabecestat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target beta-secretase 1 and beta-secretase 2. |
Classification | Small molecule |
Drug class | enzyme inhibitors: beta secretase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)C=CSC(N)=N1 |
PDB | — |
CAS-ID | 1200493-78-2 |
RxCUI | — |
ChEMBL ID | CHEMBL3916243 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 2834W8D6GK (ChemIDplus, GSRS) |